{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T04:23:18Z","timestamp":1784175798123,"version":"3.55.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Nanping Joint Funds for the innovation of science and Technology","award":["N2024LH002"],"award-info":[{"award-number":["N2024LH002"]}]},{"name":"Nanping Joint Funds for the innovation of science and Technology","award":["N2024LH002"],"award-info":[{"award-number":["N2024LH002"]}]},{"name":"Nanping Joint Funds for the innovation of science and Technology","award":["N2024LH002"],"award-info":[{"award-number":["N2024LH002"]}]},{"name":"Nanping Joint Funds for the innovation of science and Technology","award":["N2024LH002"],"award-info":[{"award-number":["N2024LH002"]}]},{"name":"Nanping Joint Funds for the innovation of science and Technology","award":["N2024LH002"],"award-info":[{"award-number":["N2024LH002"]}]},{"name":"Nanping Joint Funds for the innovation of science and Technology","award":["N2024LH002"],"award-info":[{"award-number":["N2024LH002"]}]},{"name":"Nanping Joint Funds for the innovation of science and Technology","award":["N2024LH002"],"award-info":[{"award-number":["N2024LH002"]}]},{"name":"Nanping Joint Funds for the innovation of science and Technology","award":["N2024LH002"],"award-info":[{"award-number":["N2024LH002"]}]},{"name":"Nanping Joint Funds for the innovation of science and Technology","award":["N2024LH002"],"award-info":[{"award-number":["N2024LH002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Gastric cancer(GC) is the fifth most common type of cancer worldwide and ranks third in terms of cancer-related mortality. Immunotherapy has shown promising outcomes and greatly extended survival in individuals with advanced stomach cancer. To improve the immunotherapy response in patients with GC, it is necessary to discover new molecular targets. The associations among G protein subunit gamma transducin 1(GNGT1) expression, clinicopathological features, and prognosis were assessed via the UALCAN and Kaplan-Meier databases. The CIBERSORT algorithm in R software and single-sample gene set enrichment analysis(ssGSEA) were used to analyse the proportions of infiltrating immune cells in the high-expression group and the low-expression group.GNGT1 expression was substantially greater in GC tissues than in normal tissues, and patients with GC who had high GNGT1 expression had worse clinicopathological characteristics and survival outcomes. Immunohistochemistry(IHC) experiments on stomach adenocarcinoma(STAD) samples confirmed the aberrant expression of GNGT1 and its association with a poor prognosis. Subsequent investigations revealed substantial negative correlations between GNGT1 and tumour mutational burden(TMB), microsatellite instability(MSI), immune cell infiltration, immune cell gene marker expression and immunological checkpoint expression in patients with STAD.GNGT1 is a reliable biomarker in patients with GC that also has an immunomodulatory function in this disease and may accelerate GC development by suppressing the infiltration of T cells, dendritic cells, M1 macrophages and B cells.<\/jats:p>","DOI":"10.1038\/s41598-025-08297-4","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T16:31:07Z","timestamp":1751387467000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["GNGT1 is a potential prognostic and immunologic biomarker in gastric cancer"],"prefix":"10.1038","volume":"15","author":[{"given":"Xuchong","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weifeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenquan","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"10251","key":"8297_CR1","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","volume":"396","author":"EC Smyth","year":"2020","unstructured":"Smyth, E. C. et al. Gastric cancer. Lancet 396 (10251), 635\u2013648. https:\/\/doi.org\/10.1016\/S0140-6736(20)31288-5 (2020).","journal-title":"Lancet"},{"issue":"16","key":"8297_CR2","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.3748\/wjg.v29.i16.2452","volume":"29","author":"WJ Yang","year":"2023","unstructured":"Yang, W. J. et al. Updates on global epidemiology, risk and prognostic factors of gastric cancer. World J. Gastroenterol. 29 (16), 2452\u20132468. https:\/\/doi.org\/10.3748\/wjg.v29.i16.2452 (2023).","journal-title":"World J. Gastroenterol."},{"issue":"8","key":"8297_CR3","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1002\/cac2.12193","volume":"41","author":"FH Wang","year":"2021","unstructured":"Wang, F. H. et al. The Chinese society of clinical oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer, 2021. Cancer Commun. (Lond). 41 (8), 747\u2013795. https:\/\/doi.org\/10.1002\/cac2.12193 (2021).","journal-title":"Cancer Commun. (Lond)"},{"key":"8297_CR4","doi-asserted-by":"publisher","first-page":"948647","DOI":"10.3389\/fimmu.2022.948647","volume":"13","author":"X Jin","year":"2022","unstructured":"Jin, X. et al. Recent progress and future perspectives of immunotherapy in advanced gastric Cancer. Front. Immunol. 13, 948647. https:\/\/doi.org\/10.3389\/fimmu.2022.948647 (2022).","journal-title":"Front. Immunol."},{"issue":"1","key":"8297_CR5","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1006\/geno.1996.0346","volume":"35","author":"SW Scherer","year":"1996","unstructured":"Scherer, S. W. et al. Gene structure and chromosome localization to 7q21.3 of the human rod photoreceptor transducin gamma-subunit gene (GNGT1). Genomics 35 (1), 241\u2013243. https:\/\/doi.org\/10.1006\/geno.1996.0346 (1996).","journal-title":"Genomics"},{"issue":"8","key":"8297_CR6","doi-asserted-by":"publisher","first-page":"e0272506","DOI":"10.1371\/journal.pone.0272506","volume":"17","author":"AV Kolesnikov","year":"2022","unstructured":"Kolesnikov, A. V. et al. Regulation of rod photoreceptor function by farnesylated G-protein \u03b3-subunits. PLoS One. 17 (8), e0272506. https:\/\/doi.org\/10.1371\/journal.pone.0272506 (2022).","journal-title":"PLoS One"},{"issue":"12","key":"8297_CR7","doi-asserted-by":"publisher","first-page":"8008","DOI":"10.1007\/s12035-019-1630-2","volume":"56","author":"A de-la-Torre","year":"2019","unstructured":"de-la-Torre, A. et al. Uveitis and multiple sclerosis: potential common causal mutations. Mol. Neurobiol. 56 (12), 8008\u20138017. https:\/\/doi.org\/10.1007\/s12035-019-1630-2 (2019).","journal-title":"Mol. Neurobiol."},{"issue":"3","key":"8297_CR8","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jtos.2019.03.005","volume":"17","author":"H Liang","year":"2019","unstructured":"Liang, H. et al. Correlation of clinical symptoms and signs with conjunctival gene expression in primary Sj\u00f6gren syndrome dry eye patients. Ocul Surf. 17 (3), 516\u2013525. https:\/\/doi.org\/10.1016\/j.jtos.2019.03.005 (2019).","journal-title":"Ocul Surf."},{"key":"8297_CR9","doi-asserted-by":"publisher","first-page":"946229","DOI":"10.3389\/fcvm.2022.946229","volume":"9","author":"J Cao","year":"2022","unstructured":"Cao, J. & Yuan, L. Identification of key genes for hypertrophic cardiomyopathy using integrated network analysis of differential LncRNA and gene expression. Front. Cardiovasc. Med. 9, 946229. https:\/\/doi.org\/10.3389\/fcvm.2022.946229 (2022).","journal-title":"Front. Cardiovasc. Med."},{"issue":"7","key":"8297_CR10","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/s41379-019-0209-9","volume":"32","author":"M Alsaleem","year":"2019","unstructured":"Alsaleem, M. et al. The molecular mechanisms underlying reduced E-cadherin expression in invasive ductal carcinoma of the breast: high throughput analysis of large cohorts. Mod. Pathol. 32 (7), 967\u2013976. https:\/\/doi.org\/10.1038\/s41379-019-0209-9 (2019).","journal-title":"Mod. Pathol."},{"key":"8297_CR11","doi-asserted-by":"publisher","first-page":"6696198","DOI":"10.1155\/2021\/6696198","volume":"2021","author":"JJ Zhang","year":"2021","unstructured":"Zhang, J. J. et al. Identified GNGT1 and NMU as combined diagnosis biomarker of Non-Small-Cell lung Cancer utilizing bioinformatics and logistic regression. Dis. Markers. 2021, 6696198. https:\/\/doi.org\/10.1155\/2021\/6696198 (2021).","journal-title":"Dis. Markers"},{"issue":"6","key":"8297_CR12","doi-asserted-by":"publisher","first-page":"BSR20204370","DOI":"10.1042\/BSR20204370","volume":"41","author":"Q Zheng","year":"2021","unstructured":"Zheng, Q., Min, S. & Zhou, Q. Identification of potential diagnostic and prognostic biomarkers for LUAD based on TCGA and GEO databases. Biosci. Rep. 41 (6), BSR20204370. https:\/\/doi.org\/10.1042\/BSR20204370 (2021).","journal-title":"Biosci. Rep."},{"issue":"11","key":"8297_CR13","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1089\/cmb.2019.0073","volume":"26","author":"BX Liu","year":"2019","unstructured":"Liu, B. X., Huang, G. J. & Cheng, H. B. Comprehensive analysis of core genes and potential mechanisms in rectal Cancer. J. Comput. Biol. 26 (11), 1262\u20131277. https:\/\/doi.org\/10.1089\/cmb.2019.0073 (2019).","journal-title":"J. Comput. Biol."},{"issue":"13","key":"8297_CR14","doi-asserted-by":"publisher","first-page":"3026","DOI":"10.7150\/ijms.60261","volume":"18","author":"C Ma","year":"2021","unstructured":"Ma, C., Xiong, J., Su, H. & Li, H. The underlying molecular mechanism and drugs for treatment in adrenal cortical carcinoma. Int. J. Med. Sci. 18 (13), 3026\u20133038. https:\/\/doi.org\/10.7150\/ijms.60261 (2021).","journal-title":"Int. J. Med. Sci."},{"issue":"2","key":"8297_CR15","doi-asserted-by":"publisher","first-page":"88","DOI":"10.21037\/atm-21-6935","volume":"10","author":"J Xie","year":"2022","unstructured":"Xie, J. et al. Development of a prognostic nomogram based on an eight-gene signature for esophageal squamous cell carcinoma by weighted gene co-expression network analysis (WGCNA). Ann. Transl Med. 10 (2), 88. https:\/\/doi.org\/10.21037\/atm-21-6935 (2022).","journal-title":"Ann. Transl Med."},{"key":"8297_CR16","doi-asserted-by":"publisher","first-page":"146942","DOI":"10.1016\/j.gene.2022.146942","volume":"851","author":"F Chen","year":"2023","unstructured":"Chen, F., Wang, Y., Zhang, X. & Fang, J. Five hub genes contributing to the oncogenesis and trastuzumab-resistance in gastric cancer. Gene 851, 146942. https:\/\/doi.org\/10.1016\/j.gene.2022.146942 (2023).","journal-title":"Gene"},{"key":"8297_CR17","doi-asserted-by":"publisher","unstructured":"Lin,  B. B. Proof of Poor Prognosis of Gastric cancer Patients with High Expression of PENK and GNGT1 Based on High-throughput Sequencing [D] (Fujian Medical University, 2020). https:\/\/doi.org\/10.27020\/d.cnki.gfjyu.2020.000774","DOI":"10.27020\/d.cnki.gfjyu.2020.000774"},{"key":"8297_CR18","doi-asserted-by":"publisher","first-page":"978862","DOI":"10.3389\/fimmu.2022.978862","volume":"13","author":"ZA Bazzi","year":"2023","unstructured":"Bazzi, Z. A. et al. Characterization of the immune cell landscape in CRC: clinical implications of tumour-infiltrating leukocytes in early- and late-stage CRC. Front. Immunol. 13, 978862. https:\/\/doi.org\/10.3389\/fimmu.2022.978862 (2023).","journal-title":"Front. Immunol."},{"issue":"W1","key":"8297_CR19","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li, T. et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 48 (W1), W509\u2013W514. https:\/\/doi.org\/10.1093\/nar\/gkaa407 (2020).","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"8297_CR20","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1002\/imt2.36","volume":"1","author":"W Shen","year":"2022","unstructured":"Shen, W. et al. Sangerbox: A comprehensive, interaction-friendly clinical bioinformatics analysis platform. Imeta 1 (3), e36. https:\/\/doi.org\/10.1002\/imt2.36 (2022).","journal-title":"Imeta"},{"key":"8297_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","volume":"25","author":"DS Chandrashekar","year":"2022","unstructured":"Chandrashekar, D. S. et al. UALCAN: an update to the integrated cancer data analysis platform. Neoplasia 25, 18\u201327. https:\/\/doi.org\/10.1016\/j.neo.2022.01.001 (2022).","journal-title":"Neoplasia"},{"key":"8297_CR22","doi-asserted-by":"publisher","unstructured":"Gy\u0151rffy, B. Integrated analysis of public datasets for the discovery and validation of survival-associated genes in solid tumors. Innovation (Camb). 5(3), 100625. https:\/\/doi.org\/10.1016\/j.xinn.2024.100625 (2024).","DOI":"10.1016\/j.xinn.2024.100625"},{"issue":"5","key":"8297_CR23","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami, E. et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2 (5), 401\u2013404. https:\/\/doi.org\/10.1158\/2159-8290.CD-12-0095 (2012).","journal-title":"Cancer Discov"},{"key":"8297_CR24","doi-asserted-by":"publisher","unstructured":"Kanehisa, M. et al. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53(D1), D672\u2013D677. https:\/\/doi.org\/10.1093\/nar\/gkae909 (2025).","DOI":"10.1093\/nar\/gkae909"},{"issue":"20","key":"8297_CR25","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1093\/bioinformatics\/btz210","volume":"35","author":"B Ru","year":"2019","unstructured":"Ru, B. et al. TISIDB: an integrated repository portal for tumor-immune system interactions. Bioinformatics 35 (20), 4200\u20134202. https:\/\/doi.org\/10.1093\/bioinformatics\/btz210 (2019).","journal-title":"Bioinformatics"},{"key":"8297_CR26","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1146\/annurev-pathol-042020-042741","volume":"16","author":"S Bagchi","year":"2021","unstructured":"Bagchi, S., Yuan, R. & Engleman, E. G. Immune checkpoint inhibitors for the treatment of cancer: clinical impact and mechanisms of response and resistance. Annu. Rev. Pathol. 16, 223\u2013249. https:\/\/doi.org\/10.1146\/annurev-pathol-042020-042741 (2021).","journal-title":"Annu. Rev. Pathol."},{"issue":"2","key":"8297_CR27","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1093\/bioinformatics\/btab561","volume":"38","author":"S Wang","year":"2022","unstructured":"Wang, S. et al. UCSCXenaShiny: an R\/CRAN package for interactive analysis of UCSC Xena data. Bioinformatics 38 (2), 527\u2013529. https:\/\/doi.org\/10.1093\/bioinformatics\/btab561 (2022).","journal-title":"Bioinformatics"},{"issue":"W1","key":"8297_CR28","doi-asserted-by":"publisher","first-page":"W242","DOI":"10.1093\/nar\/gkab418","volume":"49","author":"C Li","year":"2021","unstructured":"Li, C. et al. GEPIA2021: integrating multiple deconvolution-based analysis into GEPIA. Nucleic Acids Res. 49 (W1), W242\u2013W246. https:\/\/doi.org\/10.1093\/nar\/gkab418 (2021).","journal-title":"Nucleic Acids Res."},{"key":"8297_CR29","doi-asserted-by":"publisher","unstructured":"Geeleher, P., Cox, N., Huang, R. S. & pRRophetic an R package for prediction of clinical chemotherapeutic response from tumor gene expression levels. PLoS One. 9(9), e107468. https:\/\/doi.org\/10.1371\/journal.pone.0107468 (2014).","DOI":"10.1371\/journal.pone.0107468"},{"key":"8297_CR30","doi-asserted-by":"publisher","unstructured":"Chen, F., Wang, Y., Zhang, X. & Fang, J. Five hub genes contributing to the oncogenesis and trastuzumab-resistance in gastric cancer. Gene 851, 146942. https:\/\/doi.org\/10.1016\/j.gene.2022.146942 (2022).","DOI":"10.1016\/j.gene.2022.146942"},{"issue":"29","key":"8297_CR31","doi-asserted-by":"publisher","first-page":"e38979","DOI":"10.1097\/MD.0000000000038979","volume":"103","author":"R Chen","year":"2024","unstructured":"Chen, R., Yao, Z. & Jiang, L. Construction and validation of a TTN mutation associated immune prognostic model for evaluating immune microenvironment and outcomes of gastric cancer: an observational study. Med. (Baltim). 103 (29), e38979. https:\/\/doi.org\/10.1097\/MD.0000000000038979 (2024).","journal-title":"Med. (Baltim)."},{"key":"8297_CR32","doi-asserted-by":"publisher","first-page":"103841","DOI":"10.1016\/j.critrevonc.2022.103841","volume":"181","author":"MJ L\u00f3pez","year":"2023","unstructured":"L\u00f3pez, M. J. et al. Characteristics of gastric cancer around the world. Crit. Rev. Oncol. Hematol. 181, 103841. https:\/\/doi.org\/10.1016\/j.critrevonc.2022.103841 (2023).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"8297_CR33","doi-asserted-by":"publisher","first-page":"1609826","DOI":"10.3389\/pore.2021.1609826","volume":"27","author":"J Qadir","year":"2021","unstructured":"Qadir, J. et al. Implication of ARID1A undercurrents and PDL1, TP53 overexpression in advanced gastric Cancer. Pathol. Oncol. Res. 27, 1609826. https:\/\/doi.org\/10.3389\/pore.2021.1609826 (2021).","journal-title":"Pathol. Oncol. Res."},{"issue":"2","key":"8297_CR34","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10735-020-09932-2","volume":"52","author":"I Yasufuku","year":"2021","unstructured":"Yasufuku, I. et al. Prognostic significance of LDL receptor-related protein 1B in patients with gastric cancer. J. Mol. Histol. 52 (2), 165\u2013172. https:\/\/doi.org\/10.1007\/s10735-020-09932-2 (2021).","journal-title":"J. Mol. Histol."},{"key":"8297_CR35","doi-asserted-by":"publisher","first-page":"836892","DOI":"10.3389\/fmed.2022.836892","volume":"9","author":"F Zhang","year":"2022","unstructured":"Zhang, F. et al. Mutation of MUC16 is associated with tumor mutational burden and lymph node metastasis in patients with gastric Cancer. Front. Med. (Lausanne). 9, 836892. https:\/\/doi.org\/10.3389\/fmed.2022.836892 (2022).","journal-title":"Front. Med. (Lausanne)"},{"issue":"17","key":"8297_CR36","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1111\/jcmm.17847","volume":"27","author":"J Wang","year":"2023","unstructured":"Wang, J. et al. GNG4, as a potential predictor of prognosis, is correlated with immune infiltrates in colon adenocarcinoma. J. Cell. Mol. Med. 27 (17), 2517\u20132532. https:\/\/doi.org\/10.1111\/jcmm.17847 (2023).","journal-title":"J. Cell. Mol. Med."},{"issue":"10","key":"8297_CR37","doi-asserted-by":"publisher","first-page":"3572","DOI":"10.21037\/tcr-22-1377","volume":"11","author":"D Chen","year":"2022","unstructured":"Chen, D. et al. Expression of NMU, PPBP and GNG4 in colon cancer and their influences on prognosis. Transl Cancer Res. 11 (10), 3572\u20133583. https:\/\/doi.org\/10.21037\/tcr-22-1377 (2022).","journal-title":"Transl Cancer Res."},{"issue":"1","key":"8297_CR38","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/s12935-021-01935-7","volume":"21","author":"W Zhang","year":"2021","unstructured":"Zhang, W. et al. GNG5 is a novel oncogene associated with cell migration, proliferation, and poor prognosis in glioma. Cancer Cell. Int. 21 (1), 297. https:\/\/doi.org\/10.1186\/s12935-021-01935-7 (2021).","journal-title":"Cancer Cell. Int."},{"issue":"8","key":"8297_CR39","doi-asserted-by":"publisher","first-page":"BSR20201578","DOI":"10.1042\/BSR20201578","volume":"40","author":"Z Xiang","year":"2020","unstructured":"Xiang, Z. et al. Lnc GNG12-AS1 knockdown suppresses glioma progression through the AKT\/GSK-3\u03b2\/\u03b2-catenin pathway. Biosci. Rep. 40 (8), BSR20201578. https:\/\/doi.org\/10.1042\/BSR20201578 (2020).","journal-title":"Biosci. Rep."},{"issue":"11","key":"8297_CR40","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1097\/DCR.0000000000002734","volume":"66","author":"J Lv","year":"2023","unstructured":"Lv, J. et al. Identification of MKI67, TPR, and TCHH mutations as prognostic biomarkers for patients with defective mismatch repair Colon cancer stage II\/III. Dis. Colon Rectum. 66 (11), 1481\u20131491. https:\/\/doi.org\/10.1097\/DCR.0000000000002734 (2023).","journal-title":"Dis. Colon Rectum"},{"key":"8297_CR41","doi-asserted-by":"publisher","first-page":"147867","DOI":"10.1016\/j.gene.2023.147867","volume":"892","author":"N Salimian","year":"2024","unstructured":"Salimian, N. et al. Collagen 1A1 (COL1A1) and Collagen11A1(COL11A1) as diagnostic biomarkers in breast, colorectal and gastric cancers. Gene 892, 147867. https:\/\/doi.org\/10.1016\/j.gene.2023.147867 (2024).","journal-title":"Gene"},{"issue":"4","key":"8297_CR42","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1136\/gutjnl-2021-326581","volume":"72","author":"Y Fan","year":"2023","unstructured":"Fan, Y. et al. Epithelial SOX9 drives progression and metastases of gastric adenocarcinoma by promoting immunosuppressive tumour microenvironment. Gut 72 (4), 624\u2013637. https:\/\/doi.org\/10.1136\/gutjnl-2021-326581 (2023).","journal-title":"Gut"},{"issue":"1","key":"8297_CR43","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12967-022-03254-5","volume":"20","author":"Z Geng","year":"2022","unstructured":"Geng, Z. et al. MAL protein suppresses the metastasis and invasion of GC cells by interfering with the phosphorylation of STAT3. J. Transl Med. 20 (1), 50. https:\/\/doi.org\/10.1186\/s12967-022-03254-5 (2022).","journal-title":"J. Transl Med."},{"issue":"1","key":"8297_CR44","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12943-023-01733-x","volume":"22","author":"C Xia","year":"2023","unstructured":"Xia, C., Yin, S., To, K. K. W. & Fu, L. CD39\/CD73\/A2AR pathway and cancer immunotherapy. Mol. Cancer. 22 (1), 44. https:\/\/doi.org\/10.1186\/s12943-023-01733-x (2023).","journal-title":"Mol. Cancer"},{"issue":"7","key":"8297_CR45","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1002\/cbin.12022","volume":"47","author":"Z Xie","year":"2023","unstructured":"Xie, Z. et al. GRIK5 stimulates colon cancer growth and metastasis through cAMP\/PKA\/CADM3 signaling. Cell. Biol. Int. 47 (7), 1259\u20131266. https:\/\/doi.org\/10.1002\/cbin.12022 (2023).","journal-title":"Cell. Biol. Int."},{"issue":"13","key":"8297_CR46","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.3390\/cells11132020","volume":"11","author":"MB Ahmed","year":"2022","unstructured":"Ahmed, M. B. et al. cAMP signaling in cancer: A PKA-CREB and EPAC-Centric approach. Cells 11 (13), 2020. https:\/\/doi.org\/10.3390\/cells11132020 (2022).","journal-title":"Cells"},{"issue":"23","key":"8297_CR47","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.3390\/cells11233835","volume":"11","author":"A Kilanowska","year":"2022","unstructured":"Kilanowska, A., Zi\u00f3\u0142kowska, A. & Gibas-Dorna, S. P. cAMP-Dependent signaling and ovarian Cancer. Cells 11 (23), 3835. https:\/\/doi.org\/10.3390\/cells11233835 (2022).","journal-title":"Cells"},{"key":"8297_CR48","doi-asserted-by":"publisher","first-page":"1024423","DOI":"10.3389\/fendo.2022.1024423","volume":"13","author":"GB Bolger","year":"2022","unstructured":"Bolger, G. B. The cAMP-signaling cancers: Clinically-divergent disorders with a common central pathway. Front. Endocrinol. (Lausanne). 13, 1024423. https:\/\/doi.org\/10.3389\/fendo.2022.1024423 (2022).","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"20","key":"8297_CR49","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1158\/0008-5472.CAN-23-3703","volume":"84","author":"Y Zeng","year":"2024","unstructured":"Zeng, Y. et al. m6A-Mediated induction of 7-Dehydrocholesterol reductase stimulates cholesterol synthesis and cAMP signaling to promote bladder Cancer metastasis. Cancer Res. 84 (20), 3402\u20133418. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-3703 (2024).","journal-title":"Cancer Res."},{"key":"8297_CR50","doi-asserted-by":"publisher","first-page":"154921","DOI":"10.1016\/j.prp.2023.154921","volume":"252","author":"J Wu","year":"2023","unstructured":"Wu, J. et al. DNAJA1 promotes proliferation and metastasis of breast cancer by activating mutant P53\/NF-\u03baB pathway. Pathol. Res. Pract. 252, 154921. https:\/\/doi.org\/10.1016\/j.prp.2023.154921 (2023).","journal-title":"Pathol. Res. Pract."},{"key":"8297_CR51","doi-asserted-by":"publisher","first-page":"1212476","DOI":"10.3389\/fimmu.2023.1212476","volume":"14","author":"R Rui","year":"2023","unstructured":"Rui, R., Zhou, L. & He, S. Cancer immunotherapies: advances and bottlenecks. Front. Immunol. 14, 1212476. https:\/\/doi.org\/10.3389\/fimmu.2023.1212476 (2023).","journal-title":"Front. Immunol."},{"issue":"1","key":"8297_CR52","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/imr.12939","volume":"299","author":"D Michaud","year":"2021","unstructured":"Michaud, D., Steward, C. R., Mirlekar, B. & Pylayeva-Gupta, Y. Regulatory B cells in cancer. Immunol. Rev. 299 (1), 74\u201392. https:\/\/doi.org\/10.1111\/imr.12939 (2021).","journal-title":"Immunol. Rev."},{"issue":"3","key":"8297_CR53","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.ccell.2023.02.017","volume":"41","author":"CM Laumont","year":"2023","unstructured":"Laumont, C. M. & Nelson, B. H. B cells in the tumor microenvironment: Multi-faceted organizers, regulators, and effectors of anti-tumor immunity. Cancer Cell. 41 (3), 466\u2013489. https:\/\/doi.org\/10.1016\/j.ccell.2023.02.017 (2023).","journal-title":"Cancer Cell."},{"issue":"6","key":"8297_CR54","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1053\/j.gastro.2023.10.022","volume":"166","author":"C Hu","year":"2024","unstructured":"Hu, C. et al. Tertiary lymphoid Structure-Associated B cells enhance CXCL13\u2009+\u2009CD103\u2009+\u2009CD8\u2009+\u2009Tissue-Resident memory T-Cell response to programmed cell death protein 1 Blockade in Cancer immunotherapy. Gastroenterology 166 (6), 1069\u20131084. https:\/\/doi.org\/10.1053\/j.gastro.2023.10.022 (2024).","journal-title":"Gastroenterology"},{"issue":"6","key":"8297_CR55","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.3390\/ijms22062907","volume":"22","author":"Z Zeng","year":"2021","unstructured":"Zeng, Z. et al. Cell immunity in cancer: achievements and prospects. Int. J. Mol. Sci. 22 (6), 2907. https:\/\/doi.org\/10.3390\/ijms22062907 (2021).","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"8297_CR56","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1016\/j.immuni.2023.08.014","volume":"56","author":"MJ Pittet","year":"2023","unstructured":"Pittet, M. J., Di Pilato, M., Garris, C. & Mempel, T. R. Dendritic cells as shepherds of T cell immunity in cancer. Immunity 56 (10), 2218\u20132230. https:\/\/doi.org\/10.1016\/j.immuni.2023.08.014 (2023).","journal-title":"Immunity"},{"issue":"13","key":"8297_CR57","doi-asserted-by":"publisher","first-page":"6995","DOI":"10.3390\/ijms22136995","volume":"22","author":"AJ Boutilier","year":"2021","unstructured":"Boutilier, A. J. & Elsawa, S. F. Macrophage polarization States in the tumor microenvironment. Int. J. Mol. Sci. 22 (13), 6995. https:\/\/doi.org\/10.3390\/ijms22136995 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"8297_CR58","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ejca","volume":"187","author":"P Manca","year":"2023","unstructured":"Manca, P. et al. Tumour mutational burden as a biomarker in patients with mismatch repair deficient\/microsatellite instability-high metastatic colorectal cancer treated with immune checkpoint inhibitors. Eur. J. Cancer. 187, 15\u201324. https:\/\/doi.org\/10.1016\/j.ejca (2023).","journal-title":"Eur. J. Cancer"},{"issue":"2","key":"8297_CR59","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41588-018-0312-8","volume":"51","author":"RM Samstein","year":"2019","unstructured":"Samstein, R. M. et al. Tumor mutational load predicts survival after immunotherapy across multiple cancer types. Nat. Genet. 51 (2), 202\u2013206. https:\/\/doi.org\/10.1038\/s41588-018-0312-8 (2019).","journal-title":"Nat. Genet."},{"issue":"4","key":"8297_CR60","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/nsb770","volume":"9","author":"C Pargellis","year":"2002","unstructured":"Pargellis, C. et al. Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site. Nat. Struct. Biol. 9 (4), 268\u2013272. https:\/\/doi.org\/10.1038\/nsb770 (2002).","journal-title":"Nat. Struct. Biol."},{"issue":"2","key":"8297_CR61","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s00395-010-0141-0","volume":"106","author":"S Demyanets","year":"2011","unstructured":"Demyanets, S. et al. Oncostatin M-enhanced vascular endothelial growth factor expression in human vascular smooth muscle cells involves PI3K-, p38 MAPK-, Erk1\/2- and STAT1\/STAT3-dependent pathways and is attenuated by interferon-\u03b3. Basic. Res. Cardiol. 106 (2), 217\u2013231. https:\/\/doi.org\/10.1007\/s00395-010-0141-0 (2011).","journal-title":"Basic. Res. Cardiol."},{"issue":"8","key":"8297_CR62","doi-asserted-by":"publisher","first-page":"e1841","DOI":"10.1038\/cddis.2015.207","volume":"6","author":"Y Shi","year":"2015","unstructured":"Shi, Y. et al. NSC-87877 inhibits DUSP26 function in neuroblastoma resulting in p53-mediated apoptosis. Cell. Death Dis. 6 (8), e1841. https:\/\/doi.org\/10.1038\/cddis.2015.207 (2015).","journal-title":"Cell. Death Dis."},{"issue":"23","key":"8297_CR63","doi-asserted-by":"publisher","first-page":"3815","DOI":"10.1016\/j.febslet.2013.10.007","volume":"587","author":"L Xu","year":"2013","unstructured":"Xu, L. et al. Lipid raft-regulated IGF-1R activation antagonizes TRAIL-induced apoptosis in gastric cancer cells. FEBS Lett. 587 (23), 3815\u20133823. https:\/\/doi.org\/10.1016\/j.febslet.2013.10.007 (2013).","journal-title":"FEBS Lett."},{"issue":"2","key":"8297_CR64","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s12032-021-01592-w","volume":"39","author":"L Liu","year":"2022","unstructured":"Liu, L. et al. OSI-906 restores the sensitivity of ovarian clear cell carcinoma to cisplatin by targeting the IGF1R\/AKT pathway. Med. Oncol. 39 (2), 26. https:\/\/doi.org\/10.1007\/s12032-021-01592-w (2022).","journal-title":"Med. Oncol."},{"issue":"1","key":"8297_CR65","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3892\/or.2013.2819","volume":"31","author":"PD Leiphrakpam","year":"2014","unstructured":"Leiphrakpam, P. D. et al. In vivo analysis of insulin-like growth factor type 1 receptor humanized monoclonal antibody MK-0646 and small molecule kinase inhibitor OSI-906 in colorectal cancer. Oncol. Rep. 31 (1), 87\u201394. https:\/\/doi.org\/10.3892\/or.2013.2819 (2014).","journal-title":"Oncol. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08297-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08297-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08297-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T16:31:09Z","timestamp":1751387469000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08297-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8297"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-08297-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"7 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All experimental procedures were conducted according to the guidelines approved by the Ethics Committee (NPSY202405041) of Nanping First Hospital Affiliated to Fujian Medical University. The studies involving humans were approved by the Ethics Committee(SHYJS-CP-2001010) of Shanghai Outdo Biotech Co., Ltd. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"21149"}}